HRT FINANCIAL LP - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 133 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$56,000
-63.2%
12,209
-40.4%
0.01%
-87.5%
Q2 2015$152,000–20,502–0.07%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2015.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders